154 related articles for article (PubMed ID: 26662135)
1. Evidence based demonstration of the concept of 'field cancerization' by p53 expression in mirror image biopsies of patients with oral squamous cell carcinoma - an immunohistochemical study.
Hande AH; Mohite DP; Chaudhary MS; Patel M; Agarwal P; Bohra S
Rom J Morphol Embryol; 2015; 56(3):1027-33. PubMed ID: 26662135
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
3. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
4. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
[TBL] [Abstract][Full Text] [Related]
5. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of field cancerization in clinically normal oral mucosa: A systematic review and meta-analysis.
Peralta-Mamani M; Terrero-Pérez Á; Tucunduva RMA; Rubira CMF; Santos PSDS; Honório HM; Rubira-Bullen IRF
Arch Oral Biol; 2022 Nov; 143():105544. PubMed ID: 36126567
[TBL] [Abstract][Full Text] [Related]
7. p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: A study of 208 cases.
Cuevas Gonzalez JC; Gaitan Cepeda LA; Borges Yanez SA; Cornejo AD; Mori Estevez AD; Huerta ER
Indian J Pathol Microbiol; 2016; 59(2):153-8. PubMed ID: 27166031
[TBL] [Abstract][Full Text] [Related]
8. The histological characteristics of clinically normal mucosa adjacent to oral cancer.
Cankovic M; Ilic MP; Vuckovic N; Bokor-Bratic M
J Cancer Res Ther; 2013; 9(2):240-4. PubMed ID: 23771366
[TBL] [Abstract][Full Text] [Related]
9. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
[TBL] [Abstract][Full Text] [Related]
11. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
12. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
13. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.
Lee HJ; Kang YH; Lee JS; Byun JH; Kim UK; Jang SJ; Rho GJ; Park BW
BMC Oral Health; 2015 Dec; 15(1):153. PubMed ID: 26626427
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease.
Ogden GR; Chisholm DM; Morris AM; Stevenson JH
J Pathol; 1997 Jun; 182(2):180-4. PubMed ID: 9274528
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells and field cancerization of oral squamous cell carcinoma.
Simple M; Suresh A; Das D; Kuriakose MA
Oral Oncol; 2015 Jul; 51(7):643-51. PubMed ID: 25920765
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
17. p53 Expression Helps Identify High Risk Oral Tongue Pre- malignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases.
Viveka TS; Shyamsundar V; Krishnamurthy A; Ramani P; Ramshankar V
Asian Pac J Cancer Prev; 2016; 17(1):189-95. PubMed ID: 26838208
[TBL] [Abstract][Full Text] [Related]
18. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
Kushner J; Bradley G; Jordan RC
J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
de Oliveira LR; Ribeiro-Silva A; Zucoloto S
J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.
de Oliveira MG; Ramalho LM; Gaião L; Pozza DH; de Mello RA
Mol Med Rep; 2012 Jul; 6(1):163-6. PubMed ID: 22576742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
